Greater weight loss and regression to normoglycaemia, and reduced risk of T2D, at 3 years in early weight loss responders to liraglutide 3.0 mg vs early non-responders

Wilding, JPH ORCID: 0000-0003-2839-8404, Fujioka, K, Greenway, F, Lau, DCW, O'Neil, P, Jacobsen, PB, Skjoth, TV and Madsbad, S (2016) Greater weight loss and regression to normoglycaemia, and reduced risk of T2D, at 3 years in early weight loss responders to liraglutide 3.0 mg vs early non-responders. In: European Association for the Study of Diabetes, 2016-9-11 - 2016-9-15.

Text EASD2016_Wilding_Abstract 1493.pdf - Author Accepted Manuscript Download (178kB)